Sabadell Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$11.7M Sell
102,373
-5,354
-5% -$608K 2.43% 9
2023
Q1
$12.1M Buy
+107,727
New +$11.6M 2.56% 6
2021
Q3
Sell
-43,689
Closed -$3.4M 169
2021
Q2
$3.4M Buy
+43,689
New +$3.25M 0.59% 55

Other funds holding MRK

Sabadell Asset Management's MRK Position: Q2 2023 in Review

Sabadell Asset Management reduced its Merck (MRK) stake by 5% in Q2 2023, selling an estimated $608K and leaving 102,373 shares worth $11.7M. The position accounts for 2.43% of the portfolio, ranked #9.

Sabadell Asset Management first reported a position in MRK in Q2 2021 and has held it in 3 quarters since. The position peaked at $12.1M in Q1 2023. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Sabadell Asset Management held 102,373 shares of Merck worth $11.7M as of Q2 2023.
  • Sabadell Asset Management sold 5,354 Merck shares in Q2 2023, an estimated $608K.
  • Merck made up 2.43% of Sabadell Asset Management's portfolio in Q2 2023, its #9 holding.
  • Sabadell Asset Management first reported a position in Merck in Q2 2021 and has held it in 3 quarters since.
  • Sabadell Asset Management's Merck position peaked at $12.1M in Q1 2023.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.